Effect of high-dose spironolactone on protein-losing enteropathy in patients with Fontan palliation of complex congenital heart disease.
Ringel
Richard E
RE
Department of Pediatrics, Division of Pediatric Cardiology, Brady 516, Johns Hopkins School of Medicine, Johns Hopkins Hospital, 600 N. Wolfe Street, Baltimore, MD 21287, USA. rringel@jhmi.edu
Peddy
Stacie B
SB
D002648:Child; D018729:Fontan Procedure; D006330:Heart Defects, Congenital / Q000601:surgery*; D006801:Humans; D007223:Infant; D000451:Mineralocorticoid Receptor Antagonists / Q000008:administration & dosage*; D011183:Postoperative Complications; D011504:Protein-Losing Enteropathies / Q000188:drug therapy* / Q000209:etiology; D013148:Spironolactone / Q000008:administration & dosage*
D000451:Mineralocorticoid Receptor Antagonists; D013148:Spironolactone